TRANSDERMAL FENTANYL USE IN HOSPICE HOME-CARE PATIENTS WITH CHRONIC CANCER PAIN

被引:23
作者
HERBST, LH [1 ]
STRAUSE, LG [1 ]
机构
[1] SAN DIEGO HOSPICE,4311 3RD AVE,SAN DIEGO,CA 92103
关键词
CANCER; PAIN MANAGEMENT; FENTANYL; TRANSDERMAL; HOSPICE;
D O I
10.1016/0885-3924(92)90056-N
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In this study, 11 cancer patients who experienced severe pain were treated with transdermal fentanyl. Of the 11 patients, 7 completed the 4-wk protocol. Of the 4 patients who did not complete the study, 3 died due to disease progression, and 1 was withdrawn by the primary physician. Patients' pain level, mood, and quality of life were evaluated before starting the transdermal fentanyl patch system and again at 2 and 4 wk. Data from the 7 patients who completed the study showed no statistical differences in pain level, mood, or quality of life at any of the three time points. Starting doses ranged from 25-mu-g/hr to 325-mu-g/hr, with increases from 0% to 300%. There were no significant adverse reactions to the medication. The hospice patients chose to continue with the transdermal fentanyl system for pain control after completing the study.
引用
收藏
页码:S54 / S57
页数:4
相关论文
共 17 条
[11]  
Gourlay, Kowalski, Plummer, Et al., The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems, Pain, 40, pp. 21-28, (1990)
[12]  
Miser, Narang, Dothage, Young, Sindelar, Miser, Transdermal fentanyl for pain control in patients with cancer, Pain, 37, pp. 15-21, (1989)
[13]  
Food and Drug Administration, Fentanyl transdermal system approved for chronic pain, JAMA, 264, (1990)
[14]  
Huskisson, Measurement of pain, Lancet, 9, pp. 1127-1131, (1974)
[15]  
Schipper, Levitt, Quality of life in cancer trials: what is it: why measure it?, Assessment of quality of life and cancer treatment, pp. 19-29, (1986)
[16]  
Rosow, Moss, Philbin, Savarese, Histamine release during morphine and fentanyl anesthesia, Anesthesiology, 56, pp. 93-96, (1982)
[17]  
Shaw, Chandrasekaran, Transdermal therapeutic systems, Drug absorption. Proceedings of the International Conference on Drug Absorption, pp. 186-193, (1985)